This week on The Bleeding Edge of Digital Health, host Mike Moore is joined by Jani Tuomi, Digital Health Leader and co-founder of imaware. His company specializes in at-home, patient-administered customized diagnostic tests. Jani lost a loved one due to a misdiagnosis, and his company has a passion and goal for helping people make informed healthcare decisions about critical health conditions such as cardiovascular disease, and autoimmune conditions.Mike and Jani discuss the latest in precision medicine and how imaware is leading the way for providing doctors and patients with the latest, more accurate data and assessment of their health condition as quicky as possible. Listen to their entire discussion as they talk about costs, challenges, competitors, and most importantly how imaware is growing without sacrificing innovation.Notable Quotes“So, when you open this report, it speaks to you as an expert physician would. And I think that really helps patients just understand what they're looking at, understand what these results are relative to where they should be, what they could be improving, and then help map out a plan alongside either virtual care, that we can provide through telemedicine or back to their doctor and help them act on it. We've had a lot of physicians who've had patients take more reports in say, Yeah, I can trust this because I see you have this science, this expert, and I'm going to run with that.” – Jani (10:57)“We're almost at a level of infinite numbers of tests that these patients can get. So, we don't just have 18 tests off the shelf, and we sell everybody the same test. It's the biomarkers you need to give your family history, the condition, and the symptoms you think that you're presenting and the physician's thoughts on it when ordering.” – Jani (21:10)In This Episode(02:20) How did imaware come about?(06:58) The finger prick biomarkers in 2017.(09:23) How is imaware different than its competitors?(13:53) Expanding on the process for patient results and interpretation.(18:47) Expanding on the digital component of the test and its implications.(20:58) How many tests do they offer?(22:16) On building and iterating products quickly.(24:36) The shift from DTC to B2B and B2C.(27:40) How is all this paid for?(32:00) Talking about new, upcoming tech in the future.(36:59) How to focus on growth and innovate at the same time.Our GuestJani Tuomi is a digital health leader and co-founder of imaware, a company specializing in at-home, patient-administered customized diagnostic tests. Jani is passionate about helping people make informed healthcare decisions about health conditions such as cardiovascular diseases and autoimmune conditions from their own homes to engage their doctors as early as possible. 

Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health